TITLE

Dysregulation of elastin expression by fibroblasts in pulmonary emphysema: role of cellular retinoic acid binding protein 2

AUTHOR(S)
Plantier, L.; Rochette-EgIy, C.; Goven, D.; Boutten, A.; Bonay, M.; Lesëche, G.; Fournier, M.; Crestani, B.; Boczkowski, J.
PUB. DATE
November 2008
SOURCE
Thorax;Nov2008, Vol. 63 Issue 11, p1012
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: All-trans retinoic acid (ATRA) stimulates elastin synthesis by lung fibroblasts and induces alveolar regeneration in animal models of pulmonary emphysema. However, ATRA treatment has had disappointing results in human emphysema. It was hypothesised that a defect in the ATRA signalling pathway contributes to the defect of alveolar repair in the human emphysematous lung. Methods: Fibroblasts were cultured from the lung of 10 control subjects and eight patients with emphysema. Elastin and retinoic acid receptor (RAR)-β mRNAs were measured in those cells in the presence of incremental concentrations of ATRA. RARs, retinoic X receptors (RXRs) and cellular retinoic acid binding protein (CRABP) 1 and 2 mRNAs were measured as well as CRABP2 protein content. The effect of CRABP2 silencing on elastin and RAR-β expression in response to ATRA was measured in MRC5 lung fibroblasts. Results: ATRA at 10-9 M and 10-8 M increased median elastin mRNA expression by 182% and 126% in control but not in emphysema fibroblasts. RAR-13 mRNA expression was induced by ATRA in control as well as emphysema fibroblasts. RARs, RXRs and CRABP1 mRNAs were similarly expressed in control and emphysema fibroblasts while CRABP2 mRNA and protein were lower in emphysema fibroblasts. CRABP2 silencing abrogated the induction of elastin but not RAR-13 expression by ATRA in MRC5 fibroblasts. Conclusion: Pulmonary emphysema fibroblasts fail to express elastin under ATRA stimulation. CRABP2, which is necessary for elastin induction by ATRA in MRC-5 cells, is expressed at low levels in emphysema fibroblasts. This alteration in the retinoic acid signalling pathway in lung fibroblasts may contribute to the defect of alveolar repair in human pulmonary emphysema. These results are the first demonstration of the involvement of CRABP2 in elastin expression.
ACCESSION #
35420168

 

Related Articles

  • Emphysema and Metalloelastase Expression in Mouse Lung Induced by Cigarette Smoke. Valença, Samuel Santos; Da Hora, Katia; Castro, Paulo; Moraes, Vera Gonçalves; Carvalho, Laís; De Moraes Sobrino Porto, Luís Cristóvão // Toxicologic Pathology;May/Jun2004, Vol. 32 Issue 3, p351 

    Cigarette smoke (CS) causes pulmonary emphysema in humans and elastin degradation plays a key role in its pathogenesis. Previous studies on CS-exposed animals have been equivocal and have not clearly demonstrated the progression of the disease. In this study, morphometry was used to assess lung...

  • Autosomal Dominant Cutis Laxa with Severe Lung Disease: Synthesis and Matrix Deposition of Mutant Tropoelastin. Urban, Zsolt; Gao, Jimin; Pope, F .Michael; Davis, Elaine C. // Journal of Investigative Dermatology;Jun2005, Vol. 124 Issue 6, p1193 

    Cutis laxa (CL) is a heterogeneous group of genetic and acquired disorders with at least two autosomal dominant forms caused by mutations in the elastin and fibulin-5 genes, respectively. To define the molecular basis of CL in patients negative for point mutations in the elastin gene, metabolic...

  • Unilateral hyperlucent lung: Always think ACROSS. Jansari, Mahesh; Karkhanis, Vinaya; Joshi, J. M. // Lung India; 

    A picture quiz related to lung diseases is presented.

  • Roentgenographic Methods for Anatomic Diagnosis of Emphysema.  // Annals of Internal Medicine;Jul70, Vol. 73 Issue 1, p134 

    Discusses the use of physiological tests which differentiate the varieties of chronic pulmonary diseases. Information on the proposed radiographic procedure called selective alveolo-bronchography; Criteria for distinguishing the forms of emphysema.

  • The Vital Capacity in Pulmonary Emphysema. Leiner, George C.; Abramowitz, Sol; Small, Maurice J. // Annals of Internal Medicine;Jan64, Vol. 60 Issue 1, p61 

    Examines the vital capacity in pulmonary emphysema. Vital capacity and percent of forced expiratory volumes; Background on patient case reports; Diminished vital capacity in obstructive and bullous pulmonary emphysema.

  • What can naturally occurring mutations tell us about the pathogenesis of COPD? S J Marciniak // Thorax;Apr2009, Vol. 64 Issue 4, p359 

    The airway and emphysema phenotypes of chronic obstructive pulmonary disease (COPD) cluster in susceptible families. Some of this clustering is likely to be the result of shared genetic factors. There are a number of relatively rare syndromes that predispose to COPD, and a growing number of...

  • Antielastin autoimmunity in tobacco smoking—induced emphysema. Seung-Hyo Lee; Goswami, Sangeeta; Grudo, Ariel; Li-zhen Song; Bandi, Venkata; Goodnight-White, Sheila; Green, Linda; Hacken-Bitar, Joan; Huh, Joseph; Bakaeen, Faisal; Coxson, Harvey O.; Cogswell, Sebastian; Storness-Bliss, Claudine; Corry, David B.; Kheradmand, Farrah // Nature Medicine;May2007, Vol. 13 Issue 5, p567 

    Chronic obstructive pulmonary disease and emphysema are common destructive inflammatory diseases that are leading causes of death worldwide. Here we show that emphysema is an autoimmune disease characterized by the presence of antielastin antibody and T-helper type 1 (TH1) responses, which...

  • Systemic elastin degradation in chronic obstructive pulmonary disease. Maclay, John D.; McAllister, David A.; Rabinovich, Roberto; Haq, Imran; Maxwell, Scott; Hartland, Stephen; Connell, Martin; Murchison, John T.; van Beek, Edwin J. R.; Gray, Robert D.; Mills, Nicholas L.; MacNee, William // Thorax;Jul2012, Vol. 67 Issue 7, p606 

    Background Development of emphysema and vascular stiffness in chronic obstructive pulmonary disease (COPD) may be due to a common mechanism of susceptibility to pulmonary and systemic elastin degradation. Objectives To investigate whether patients with COPD have evidence of systemic elastin...

  • Therapeutic Potential of Growth Factors in Pulmonary Emphysematous Condition. Muyal, Jai; Muyal, Vandana; Kotnala, Sudhir; Kumar, Dhananjay; Bhardwaj, Harsh // Lung;Apr2013, Vol. 191 Issue 2, p147 

    Pulmonary emphysema is a major manifestation of chronic obstructive pulmonary disease (COPD), which is characterized by progressive destruction of alveolar parenchyma with persistent inflammation of the small airways. Such destruction in the distal respiratory tract is irreversible and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics